Therapeutic strategy for handling inherited retinal degenerations in a gene-independent manner using rod-derived cone viability factors

C R Biol. 2014 Mar;337(3):207-13. doi: 10.1016/j.crvi.2013.12.002. Epub 2014 Feb 20.

Abstract

The most common hereditary retinal degeneration, retinitis pigmentosa (RP), leads to blindness by degeneration of cone photoreceptors. Meanwhile, genetic studies have shown that a significant proportion of RP genes is expressed only by rods, which raises the question of the mechanism leading to the degeneration of cones. Following the concept of sustainability factor cones, rods secrete survival factors that are necessary to maintain the cones, named Rod-derived Cone Viability Factors (RdCVFs). In patients suffering from RP, loss of rods results in the loss of RdCVFs expression and followed by cone degeneration. We have identified the bifunctional genes nucleoredoxin-like 1 and 2 that encode for, by differential splicing, a thioredoxin enzyme and a cone survival factor, respectively RdCVF and RdCVF2. The administration of these survival factors would maintain cones and central vision in most patients suffering from RP.

Keywords: Cone photoreceptors; Nucleoredoxin-like; Photorécepteurs à cône; Redox signalling; Signalisation redox; TAU; Thioredoxin; Thiorédoxine; Vision.

Publication types

  • Review

MeSH terms

  • Genetic Therapy / methods*
  • Humans
  • Retinal Cone Photoreceptor Cells / pathology
  • Retinal Degeneration / drug therapy*
  • Retinal Degeneration / genetics*
  • Retinal Degeneration / pathology
  • Retinal Rod Photoreceptor Cells / pathology
  • Retinitis Pigmentosa / drug therapy
  • Retinitis Pigmentosa / pathology
  • Thioredoxins / genetics*
  • Thioredoxins / therapeutic use*

Substances

  • NXNL1 protein, human
  • Thioredoxins